Search the website

Search results

121 results

Sort by

List item

Ciclosporin (systemic use): List of nationally authorised products - PSUSA/00000745/201812 (PDF/578.14 KB)

Last updated: 16/09/2019
Active substance: ciclosporin
Procedure number: PSUSA/00000745/201812
Regulatory outcome: Maintenance
List item

Camellia sinensis, Leaf, Dry extract refined (derived from Camellia sinensis, L. O.KUNTZE) (topical use): List of nationally authorised products - PSUSA/00010569/201812

Last updated: 16/09/2019
Active substance: Camellia sinensis
Procedure number: PSUSA/00010569/201812
Regulatory outcome: Maintenance
List item

Caffeine / ergotamine: List of nationally authorised products - PSUSA/00000485/201811 (PDF/88.1 KB)

Last updated: 16/09/2019
Active substance: Caffeine, ergotamine
Procedure number: PSUSA/00000485/201811
Regulatory outcome: Maintenance
List item

Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure): List of nationally authorised products - PSUSA/00010693/201901 (PDF/74.27 KB)

Last updated: 11/09/2019
Active substance: ASMF
Procedure number: PSUSA/00010693/201901
Regulatory outcome: Maintenance
List item

Flunitrazepam: List of nationally authorised medicinal products - PSUSA/00001418/201901 (PDF/70.13 KB)

Last updated: 11/09/2019
Active substance: flunitrazepam
Procedure number: PSUSA/00001418/201901
Regulatory outcome: Maintenance
List item

Bezafibrate: List of nationally authorised products - PSUSA/00000405/201901 (PDF/89.85 KB)

Last updated: 10/09/2019
Active substance: bezafibrate
Procedure number: PSUSA/00000405/201901
Regulatory outcome: Maintenance
List item

Biotin: List of nationally authorised medicinal products - PSUSA/00000414/201901 (PDF/46.44 KB)

Last updated: 10/09/2019
Active substance: Biotin
Procedure number: PSUSA/00000414/201901
Regulatory outcome: Maintenance
List item

Niflumic acid: List of nationally authorised products - PSUSA/00002157/201812 (PDF/82.75 KB)

Last updated: 10/09/2019
Active substance: niflumic acid
Procedure number: PSUSA/00002157/201812
Regulatory outcome: Maintenance
List item

Benzydamine / cetylpyridine: List of nationally authorised medicinal products - PSUSA/00000378/201901 (PDF/186.08 KB)

Last updated: 10/09/2019
Active substance: benzydamine, cetylpyridine
Procedure number: PSUSA/00000378/201901
Regulatory outcome: Maintenance
List item

Landiolol: List of nationally authorised medicinal products - PSUSA/00010570/201902 (PDF/134.08 KB)

Last updated: 09/09/2019
Active substance: landiolol
Procedure number: PSUSA/00010570/201902
Regulatory outcome: Maintenance
List item

Tiapride: List of nationally authorised medicinal products - PSUSA/00002944/201807 (PDF/235.19 KB)

Last updated: 21/05/2019
Active substance: tiapride
Procedure number: PSUSA/00002944/201807
Regulatory outcome: Maintenance
List item

Alfentanil: List of nationally authorised medicinal products - PSUSA/00000082/201809 (PDF/111.77 KB)

Last updated: 21/05/2019
Active substance: alfentanil
Procedure number: PSUSA/00000082/201809
Regulatory outcome: Maintenance
List item

Dienogest / estradiol (contraception indication): List of nationally authorised medicinal products - PSUSA/00010444/201809 (PDF/98.85 KB)

Last updated: 21/05/2019
Active substance: Dienogest, estradiol
Procedure number: PSUSA/00010444/201809
Regulatory outcome: Maintenance
List item

Opium: List of nationally authorised medicinal products - PSUSA/00010670/201808 (PDF/179.84 KB)

Last updated: 21/05/2019
Active substance: opium
Procedure number: PSUSA/00010670/201808
Regulatory outcome: Maintenance
List item

Finasteride: List of nationally authorised medicinal products - PSUSA/00001392/201808 (PDF/130.82 KB)

Last updated: 25/04/2019
Active substance: Finasteride
Procedure number: PSUSA/00001392/201808
Regulatory outcome: Maintenance
List item

Aztreonam: List of nationally authorised medicinal products - PSUSA/00010178/201808 (PDF/116.02 KB)

Last updated: 17/04/2019
Active substance: Aztreonam
Procedure number: PSUSA/00010178/201808
Regulatory outcome: Maintenance
List item

Ciclesonide: List of nationally authorised medicinal products - PSUSA-00000742-201808 (PDF/137.66 KB)

Last updated: 17/04/2019
Active substance: ciclesonide
Procedure number: PSUSA-00000742-201808
Regulatory outcome: Maintenance
List item

Rilmenidine: List of nationally authorised medicinal products - PSUSA-00002643-201808 (PDF/100.44 KB)

Last updated: 17/04/2019
Active substance: rilmenidine
Procedure number: PSUSA-00002643-201808
Regulatory outcome: Maintenance
List item

Patent blue V sodium: List of nationally authorised medicinal products - PSUSA/00002320/201804 (PDF/72.2 KB)

Last updated: 24/01/2019
Active substance: patent blue V sodium
Procedure number: PSUSA/00002320/201804
Regulatory outcome: Maintenance
List item

Enalapril: List of nationally authorised medicinal products - PSUSA/00001211/201803 (PDF/141 KB)

Last updated: 19/12/2018
Active substance: enalapril
Procedure number: PSUSA/00001211/201803
Regulatory outcome: Maintenance
List item

Dihydroergotamine: List of nationally authorised medicinal products - PSUSA/00001075/201804 (PDF/87.65 KB)

Last updated: 07/12/2018
Active substance: dihydroergotamine
Procedure number: PSUSA/00001075/201804
Regulatory outcome: Maintenance
List item

Human anti-d immunoglobulin: List of nationally authorised medicinal products - PSUSA/00001614/201803 (PDF/163 KB)

Last updated: 06/12/2018
Active substance: human anti-d immunoglobulin
Procedure number: PSUSA/00001614/201803
Regulatory outcome: Maintenance
List item

Foscarnet: List of nationally authorised medicinal products - PSUSA/00001472/201803 (PDF/73.09 KB)

Last updated: 05/12/2018
Active substance: foscarnet
Procedure number: PSUSA/00001472/201803
Regulatory outcome: Maintenance
List item

Ioxaglic acid: List of nationally authorised medicinal products - PSUSA/00001777/201802 (PDF/362.29 KB)

Last updated: 19/11/2018
Active substance: ioxaglic acid
Procedure number: PSUSA/00001777/201802
Regulatory outcome: Maintenance
List item

BCG (bacillus calmette-guérin) for immunotherapy: List of nationally authorised medicinal products - PSUSA/00000303/201803 (PDF/80.06 KB)

Last updated: 19/11/2018
Active substance: BCG (bacillus calmette-guérin) for immunotherapy
Procedure number: PSUSA/00000303/201803
Regulatory outcome: Maintenance

121 results

Ciclosporin (systemic use): List of nationally authorised products - PSUSA/00000745/201812 (PDF/578.14 KB)

Camellia sinensis, Leaf, Dry extract refined (derived from Camellia sinensis, L. O.KUNTZE) (topical use): List of nationally authorised products - PSUSA/00010569/201812

Caffeine / ergotamine: List of nationally authorised products - PSUSA/00000485/201811 (PDF/88.1 KB)

Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure): List of nationally authorised products - PSUSA/00010693/201901 (PDF/74.27 KB)

Flunitrazepam: List of nationally authorised medicinal products - PSUSA/00001418/201901 (PDF/70.13 KB)

Bezafibrate: List of nationally authorised products - PSUSA/00000405/201901 (PDF/89.85 KB)

Biotin: List of nationally authorised medicinal products - PSUSA/00000414/201901 (PDF/46.44 KB)

Niflumic acid: List of nationally authorised products - PSUSA/00002157/201812 (PDF/82.75 KB)

Benzydamine / cetylpyridine: List of nationally authorised medicinal products - PSUSA/00000378/201901 (PDF/186.08 KB)

Landiolol: List of nationally authorised medicinal products - PSUSA/00010570/201902 (PDF/134.08 KB)

Tiapride: List of nationally authorised medicinal products - PSUSA/00002944/201807 (PDF/235.19 KB)

Alfentanil: List of nationally authorised medicinal products - PSUSA/00000082/201809 (PDF/111.77 KB)

Dienogest / estradiol (contraception indication): List of nationally authorised medicinal products - PSUSA/00010444/201809 (PDF/98.85 KB)

Opium: List of nationally authorised medicinal products - PSUSA/00010670/201808 (PDF/179.84 KB)

Finasteride: List of nationally authorised medicinal products - PSUSA/00001392/201808 (PDF/130.82 KB)

Aztreonam: List of nationally authorised medicinal products - PSUSA/00010178/201808 (PDF/116.02 KB)

Ciclesonide: List of nationally authorised medicinal products - PSUSA-00000742-201808 (PDF/137.66 KB)

Rilmenidine: List of nationally authorised medicinal products - PSUSA-00002643-201808 (PDF/100.44 KB)

Patent blue V sodium: List of nationally authorised medicinal products - PSUSA/00002320/201804 (PDF/72.2 KB)

Enalapril: List of nationally authorised medicinal products - PSUSA/00001211/201803 (PDF/141 KB)

Dihydroergotamine: List of nationally authorised medicinal products - PSUSA/00001075/201804 (PDF/87.65 KB)

Human anti-d immunoglobulin: List of nationally authorised medicinal products - PSUSA/00001614/201803 (PDF/163 KB)

Foscarnet: List of nationally authorised medicinal products - PSUSA/00001472/201803 (PDF/73.09 KB)

Ioxaglic acid: List of nationally authorised medicinal products - PSUSA/00001777/201802 (PDF/362.29 KB)

BCG (bacillus calmette-guérin) for immunotherapy: List of nationally authorised medicinal products - PSUSA/00000303/201803 (PDF/80.06 KB)